Cite Filings / TWST / 0001644956-25-000008
Feed Companies Filings Check
Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

Twist Bioscience Corp · Filed 2025-02-12 · Acc 0001644956-25-000008

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2025-03-07 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-02-12 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-02-12 S-8 Securities Offered to Employees in Benefit Plans
  • 2025-02-11 4 Director sold 2,940 shares at $53.14 ($156,217)
  • 2025-02-11 8-K Executive or director change · Bylaws or fiscal year change · Shareholder vote results
  • 2025-02-07 4 Director acquired 4,472 shares (grant or award)
  • 2025-01-10 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · T. Rowe Price Associates, Inc. 9.2%
  2. 2026-08-14 SCHEDULE 13G/A · EdgePoint Investment Group Inc. 4.21%
  3. 2026-02-17 SCHEDULE 13G/A · EdgePoint Investment Group Inc. 8.80%
  4. 2025-11-14 SCHEDULE 13G · EdgePoint Investment Group Inc. 6.76%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…